Search results
3 Things You Need to Know If You Buy Novavax Today
The Motley Fool via AOL· 3 days agoThat's why Sanofi's agreement to co-commercialize Novavax's vaccine as of next year is such positive news for the smaller company. In addition, Sanofi...
Novavax Unusual Options Activity For May 23 - Novavax (NASDAQ:NVAX)
Benzinga· 1 day agoThe company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly ...
Why Novavax (NVAX) Stock Price Appreciated 14% on Monday
Zacks via Yahoo Finance· 3 days agoNovavax (NVAX) surges after one of its top shareholders drops a proxy campaign against the company....
Better Buy: Inovio Pharmaceuticals vs. Novavax
Motley Fool via Yahoo Finance· 2 days agoWhich of these two biotechs can outperform the other moving forward? Let's take a look. NVAX data by YCharts The case for Novavax Novavax earned approval...
Moderna and Novavax Hope for Early Launch of This Year’s Covid-19 Shots, Despite FDA Delay
Barrons.com· 4 days agovaccine makers say that the Food and Drug Administration’s delay in designing this fall’s Covid-19 ...
Vaccine Stocks Rise on Growing Threat of Bird Flu Infections
Zacks via Yahoo Finance· 1 day agoThe Biden administration is reportedly in talks with vaccine makers Moderna (MRNA) and Pfizer (PFE)...
The Next Novavax? 3 Biopharma Stocks to Buy Before They Boom
InvestorPlace· 1 day agoNovavax (NASDAQ:NVAX) stock was among the laggards in the race for the vaccine against COVID-19....
This Stock Just More Than Doubled in 1 Day: Is It a Buy? | The Motley Fool
The Motley Fool· 5 days agoThe biotech has come a long way since its not-so-successful attempt at dominating the coronavirus ...
This Stock Just More Than Doubled in 1 Day: Is It a Buy?
Motley Fool via Yahoo Finance· 5 days agoVaccine maker Novavax (NASDAQ: NVAX) isn't dead in the water after all. Though the past 18 months...
Is Novavax Stock a Buy?
Motley Fool via Yahoo Finance· 6 days agoRival Moderna announced earlier this year that it would be pausing plans to build a plant in Kenya for vaccine development due to a drop in demand for...
